Dr. Marmarelis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3400 Civic Center Blvd
2 West
Philadelphia, PA 19104Phone+1 215-615-5121- Is this information wrong?
Summary
- Dr. Melina Marmarelis is an oncologist in Philadelphia, PA and is affiliated with multiple hospitals in the area, including Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center. She received her medical degree from Harvard Medical School and has been in practice 4 years. She is experienced in lung cancer and medical education.
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2016 - 2019
Brigham and Women's HospitalResidency, Internal Medicine, 2013 - 2016
Harvard Medical SchoolClass of 2013
Certifications & Licensure
PA State Medical License 2016 - 2024
MA State Medical License 2013 - 2016- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Brief Report: Impact of Reflex Testing on Tissue-Based Molecular Genotyping in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer.Melina E Marmarelis, Dylan G Scholes, Cindy M McGrath, Salvatore F Priore, Jacquelyn J Roth, Michael Feldman, Jennifer J D Morrissette, Leslie Litzky, Charu Deshpande,...> ;Clinical Lung Cancer. 2024 Mar 12
- The Efficacy and Safety of Treating Acquired MET Resistance Through Combinations of Parent and MET Tyrosine Kinase Inhibitors in Patients With Metastatic Oncogene-Driv...Tejas Patil, Alyse Staley, Yunan Nie, Mandy Sakamoto, Margaret Stalker, James M Jurica, Kenna Koehler, Amanda Cass, Halle Kuykendall, Emily Schmitt, Emma Filar, Evelin...> ;JTO Clinical and Research Reports. 2024 Feb 1
- Plunging Into the PACIFIC: Outcomes of Patients With Unresectable KRAS-Mutated Non-Small Cell Lung Cancer Following Definitive Chemoradiation and Durvalumab Consolidat...Barsouk, A., Friedes, C., Iocolano, M., Doucette, A., Cohen, R., Robinson, K., D'Avella, C., Marmarelis, M., Kosteva, J., Singh, A., Ciunci, C., Levin, W., Cengel, K.,...> ;Clinical Lung Cancer. 2023 Dec 22
- Join now to see all
Press Mentions
Pembrolizumab Active in Diffuse Malignant Peritoneal MesotheliomaApril 20th, 2023- Party with a Purpose Benefits AACR and Supports Lung Cancer ResearchOctober 27th, 2022
- Brain MRI Surveillance Needed for TKI-Treated ALK or ROS1-Positive NSCLCJune 30th, 2022
Professional Memberships
- Member
Hospital Affiliations
Hospital of the University of PennsylvaniaPhiladelphia, Pennsylvania- Penn Presbyterian Medical CenterPhiladelphia, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
